Insider: Blackman Samuel C. HEAD OF R&D - Day One Biopharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,034,015 | 0 | 1,034,015 |
| Value | $7,031,302.00 | $0.00 | $7,031,302.00 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 12/10/2024 | DDS | 30,000 | Direct | COM | $13.31 | $399,339.00 | 1,034,015 |
| 11/18/2024 | DDS | 2,206 | Direct | COM | $13.21 | $29,141.70 | 1,064,015 |
| 11/11/2024 | DDS | 10,000 | Direct | COM | $16.10 | $160,994.00 | 1,057,535 |
| 11/08/2024 | DDS | 18,255 | Direct | COM | $16.17 | $295,228.99 | 1,067,535 |
| 11/07/2024 | DDS | 11,245 | Direct | COM | $16.03 | $180,286.59 | 1,085,790 |
| 10/31/2024 | DDS | 500 | Direct | COM | $16.02 | $8,010.00 | 1,097,035 |
| 09/10/2024 | DDS | 30,000 | Direct | COM | $14.22 | $426,675.00 | 1,097,535 |
| 08/16/2024 | DDS | 2,232 | Direct | COM | $14.00 | $31,245.99 | 1,127,535 |
| 07/16/2024 | DDS | 20,000 | Direct | COM | $16.01 | $320,226.00 | 1,121,081 |
| 06/10/2024 | DDS | 30,000 | Direct | COM | $12.62 | $378,588.00 | 1,141,081 |
| 05/16/2024 | DDS | 2,267 | Direct | COM | $16.08 | $36,450.41 | 1,171,081 |
| 05/10/2024 | DDS | 10,000 | Direct | COM | $16.37 | $163,743.00 | 1,164,662 |
| 04/18/2024 | DDS | 10,000 | Direct | COM | $16.02 | $160,163.00 | 1,174,662 |
| 03/25/2024 | DDS | 10,000 | Direct | COM | $16.01 | $160,055.00 | 1,184,662 |
| 03/11/2024 | DDS | 30,000 | Direct | COM | $15.24 | $457,314.00 | 1,194,662 |
| 02/27/2024 | DDS | 20,000 | Direct | COM | $16.11 | $322,166.00 | 1,224,662 |
| 02/16/2024 | DDS | 2,258 | Direct | COM | $15.25 | $34,430.21 | 1,244,662 |
| 11/16/2023 | DDS | 709 | Direct | COM | $11.69 | $8,288.21 | 1,238,234 |
| 08/17/2023 | DDS | 668 | Direct | COM | $13.86 | $9,258.48 | 1,236,319 |
| 06/05/2023 | DDS | 1,229 | Direct | COM | $16.00 | $19,664.00 | 1,234,363 |
| 05/16/2023 | DDS | 692 | Direct | COM | $13.12 | $9,080.63 | 1,235,592 |
| 03/10/2023 | DDS | 10,000 | Direct | COM | $18.05 | $180,484.00 | 1,233,660 |
| 02/16/2023 | DDS | 674 | Direct | COM | $19.57 | $13,192.20 | 1,243,660 |
| 01/10/2023 | DDS | 7,500 | Direct | COM | $22.75 | $170,632.50 | 1,252,648 |
| 01/10/2023 | DDS | 2,500 | Direct | COM | $23.20 | $58,011.25 | 1,250,148 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research